Trump’s 2025 tariff policy initially exempted certain goods, like pharmaceuticals and semiconductors, from the 10% baseline and reciprocal tariffs. The administration aims to protect U.S. industries, but debates persist over whether exemptions undermine the strategy or prevent shortages and price spikes worldwide.